news and press releases
Here you'll find our latest blog posts, published clinical trials, and latest news about at-home testing with YourBio Health. We're glad you're here!
YourBio Health's TAP® Micro Select Secures FDA 510(k) Medical Device Clearance for Producing Capillary Whole Blood Samples
BOSTON, April 24, 2023 /PRNewswire/ -- YourBio Health, Inc, the developers of the world's first virtually painless push-button blood collection device, announced today that TAP® Micro Select received 510(k) Medical Device clearance from the U.S. Food and Drug Administration (FDA). Touch Activated Phlebotomy (TAP®) was developed over the last 15 years to deliver on the goal of developing both painless and remote blood collection

YourBio Health's TAP® Micro Select Secures FDA 510(k) Medical Device Clearance for Producing Capillary Whole Blood Samples
BOSTON, April 24, 2023 /PRNewswire/ -- YourBio Health, Inc, the developers of the world's first virtually painless push-button blood collection device, announced today that TAP® Micro Select received 510(k) Medical Device clearance from the U.S. Food and Drug Administration (FDA). Touch Activated Phlebotomy (TAP®) was developed over the last 15 years to deliver on the goal of developing both painless and remote blood collection

Losing Sight of Land
By: Flagship Pioneering
YourBio Health is proud to be among the companies that help unlock preemptive health and medicines with Flagship Pioneering.
.png?width=400&height=283&name=MicrosoftTeams-image%20(3).png)
Losing Sight of Land
By: Flagship Pioneering
YourBio Health is proud to be among the companies that help unlock preemptive health and medicines with Flagship Pioneering.
YourBio Health Delivers Superior Method for At-home Serum Anti-Mullerian Hormone Testing
TAP® II Device delivers superior correlation and fewer false positives versus the DBS ADx 100 card and a significantly preferred experience to venipuncture.

YourBio Health Delivers Superior Method for At-home Serum Anti-Mullerian Hormone Testing
TAP® II Device delivers superior correlation and fewer false positives versus the DBS ADx 100 card and a significantly preferred experience to venipuncture.
- At-home blood collection facilitates patient participation in COVID-19 study
4 August 2022 - YourBio Health launches nearly painless, at-home COVID-19 antibody test
13 September 2021 - Stephen Hahn, M.D., former U.S. FDA Commissioner, joins YourBio Health as interim Chief Medical Officer
9 September 2021 - Seventh Sense Biosystems Unveils New Name: YourBio Health; Raises $21m Funding to Help Fuel Growth
31 August 2021 - Seventh Sense Blood Collection Technology Key Part of Gateway Genomics’ SneakPeek Snap for Gender DNA Test
29 June 2021 - HumanPeople Incorporate TAP II for Home Collection of Blood Samples
5 March 2021 - Seventh Sense Biosystems Expands to European Markets for Consumer Blood Collection with TAP II CE Marking
2 February 2021
blogs and whitepapers
Enable remote access multiomics with just one TAP
Use of TAP Point of Care Blood Collection Device for Targeted Proteomics with the Olink Target 96 Cardiovascular II Panel Using Proximity Extension Assay Technology.

Enable remote access multiomics with just one TAP
Use of TAP Point of Care Blood Collection Device for Targeted Proteomics with the Olink Target 96 Cardiovascular II Panel Using Proximity Extension Assay Technology.
TAP® technology shows promise for early, precise Alzheimer's monitoring via biomarkers
Use of the TAP Point of Care Blood Collection Device for Biomarker Assessments on the Quanterix Simoa HD-X Platform: Initial Feasibility for Plasma Biomarkers in Alzheimer’s Disease Detection.

TAP® technology shows promise for early, precise Alzheimer's monitoring via biomarkers
Use of the TAP Point of Care Blood Collection Device for Biomarker Assessments on the Quanterix Simoa HD-X Platform: Initial Feasibility for Plasma Biomarkers in Alzheimer’s Disease Detection.

How YourBio Health Came To Be:
The Evolution of the TAP® Device
By: Jessica Wakefield and Ping Gong
TAP® II devices, involves collecting a small blood samples that improves the patient experience, because it’s easier to use than other self-sampling devices.

How YourBio Health Came To Be:
The Evolution of the TAP® Device
By: Jessica Wakefield and Ping Gong
TAP® II devices, involves collecting a small blood samples that improves the patient experience, because it’s easier to use than other self-sampling devices.
- How ImYoo is decentralizing immune profiling at single-cell resolution
- This whitepaper describes ImYoo's end-to-end platform which integrates YourBio Health’s TAP II virtually painless at-home blood collection device, multiplexed single-cell RNA sequencing, and automated data analysis. With this platform ImYoo is creating a growing capillary blood single-cell RNA sequencing (scRNA-seq) database with a resolution of 40 cell subtypes.
external publications using YourBio Health's devices
- 23 January 2023 - Quantification of Severe Acute Respiratory Syndrome Coronavirus 2 Binding Antibody Levels To Assess Infection and Vaccine-Induced Immunity Using WHO Standards
- TAP sample collection in decentralized drive-through settings enabled a comprehensive evaluation of Sars-CoV-2 antibody level and decay using WHO standards in a representative population of LA county during the pandemic.
- 11 October 2022 - Relationship between Anti-Spike Antibodies and Risk of SARS-CoV-2 Infection in Infants Born to COVID-19 Vaccinated Mothers
- TAP devices used to collect blood samples from 2-month-old and 6-month-old infants in Sars-CoV-2 infection risk study.
- 1 September 2022 - Evaluation of at-home serum anti-Müllerian hormone testing: a head-to-head comparison study
- The TAP devices was not only more accurate than the alternative at-home serum AMH test visa the Adx card, but also had significantly lower pain and high patient satisfaction scores.
- 2 August 2022 - Antibody Response Following COVID-19 Boosters During the Omicron Wave in the United States: A Decentralized, Digital Health, Real World Study
- TAP devices successfully used to collect samples in siteless trial on covid antibody response study following booster shot. YourBio's API platform enabled seamless integration.
- 7 March 2022 - Durability of Anti-Spike Antibodies in Infants After Maternal COVID-19 Vaccination or Natural Infection
- TAP devices used to collect blood samples from 2-month-old and 6-month-old infants in Sars-CoV-2 infection risk study
- 1 October 2021 - Safety and Reactogenicity of 2 Doses of SARS-CoV-2 Vaccination in Solid Organ Transplant Recipients
- Remote sample collection with TAP device was adopted by transplant patients as an alternative to traditional venous draw for measurement of anti-SARS-CoV-2 antibodies test.
- 1 September 2021 - Immunogenicity and Reactogenicity After SARS-CoV-2 mRNA Vaccination in Kidney Transplant Recipients Taking Belatacept
- Remote sample collection with TAP device was adopted by transplant patients as an alternative to traditional venous draw for measurement of anti-SARS-CoV-2 antibodies test.
- 6 August 2021 - SARS-CoV-2 messenger RNA vaccine antibody response and reactogenicity in heart and lung transplant recipients
- Remote sample collection with TAP device was adopted by transplant patients as an alternative to traditional venous draw for measurement of anti-SARS-CoV-2 antibodies test.
- 4 June 2021 - SneakPeek snap: a painless microneedle-based pushbutton device for early fetal sex determination
- Gateway SNAP, OEM device based on TAP design, was highly preferred over fingerstick by customers, with >99% accuracy for fetal gender sex determination.
- 5 May 2021 - Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients
- TAP II used to collect samples for measurement of anti-SARS-CoV-2 antibodies in heart and lung transplant patients (n=134 HT, n=103 LT)
- 1 May 2021 - Early Development and Durability of SARS-CoV-2 Antibodies Among Solid Organ Transplant Recipients: A Pilot Study
- Remote sample collection with TAP device was first offered to transplant patients as an alternative to traditional venous draw for measurement of anti-SARS-CoV-2 antibodies test.
- 15 March 2021 - Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients
- Remote sample collection with TAP device was adopted by transplant patients as an alternative to traditional venous draw for measurement of anti-SARS-CoV-2 antibodies test.
- 25 November 2020 - Single cell profiling of capillary blood enables out of clinic human immunity studies
- TAP device was validated for research use monitoring variation in human immune system within day and day-to-day.
- 5 June 2020 - Metabolomics of Endurance Capacity in World Tour Professional Cyclists
- TAP device enabled blood sample collections on athletes in the field for measurement of metabolites
- 16 April 2020 - Fully automated dried blood spot sample preparation enables the detection of lower molecular mass peptide and non-peptide doping agents by means of LC-HRMS
- TAP device validated in conjunction with dried blood spot testing for panel of doping analytes
- 9 December 2019 - Volumetric Absorptive Microsampling (VAMS) technology for IGF-1 quantification by automated chemiluminescent immunoassay in dried blood
- TAP device was suitable for the measurement of IGF-1 in athlete samples
- 29 April 2019 - The Effects of Whole-Body Photobiomodulation Light-Bed Therapy on Creatine Kinase and Salivary Interleukin-6 in a Sample of Trained Males: A Randomized, Crossover Study
- 23 March 2019 - Correlation of Capillary and Venous Plasma Measurement of Anti-Mullerian Hormone
- TAP device was suitable for measuring Anti-Müllerian Hormone with the standard reference interval
- 12 July 2018 - Quantitative metabolomics comparison of traditional blood draws and TAP capillary blood collection
- TAP device may be a logistically-friendly source of blood for large scale metabolomics studies—especially those addressing amino acids, glycemia and lactatemia as well as bile acids, acyl-carnitine levels.